159 related articles for article (PubMed ID: 15884107)
1. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.
Peng C; Zhou RL; Shao GZ; Rui JA; Wang SB; Lin M; Zhang S; Gao ZF
World J Gastroenterol; 2005 May; 11(18):2704-8. PubMed ID: 15884107
[TBL] [Abstract][Full Text] [Related]
2. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.
Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX
World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524
[TBL] [Abstract][Full Text] [Related]
3. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma.
Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A
Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
[TBL] [Abstract][Full Text] [Related]
6. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M
Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487
[TBL] [Abstract][Full Text] [Related]
7. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
8. [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene].
Liu X; Zhou R; Zhang Q; Zhang Y; Shao G; Jin Y; Zhang S; Lin M; Rui J; Ye D
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):340-7. PubMed ID: 12947545
[TBL] [Abstract][Full Text] [Related]
9. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients.
Yang H; Lin M; Xiong F; Yang Y; Nie X; McNutt MA; Zhou R
Surg Today; 2011 Jun; 41(6):810-7. PubMed ID: 21626328
[TBL] [Abstract][Full Text] [Related]
10. [Correlaion between serum Golph2 protein and hepatocellular carcinoma].
Tan LY; Chen J; Wang H; Ye HQ; Li Q; Gu JA; Han LQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):288-91. PubMed ID: 19403029
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
12. [Serum LAPTM4B-35 protein as a novel diagnostic marker for hepatocellular carcinoma].
Pang Y; Zhang S; Yang H; Zhou RL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):710-715. PubMed ID: 34393233
[TBL] [Abstract][Full Text] [Related]
13. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.
Liu X; Xiong F; Wei X; Yang H; Zhou R
Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073
[TBL] [Abstract][Full Text] [Related]
14. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
15. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer.
Zhang H; Tian B; Yu H; Yao H; Gao Z
Tumour Biol; 2014 Dec; 35(12):12737-42. PubMed ID: 25416438
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
[TBL] [Abstract][Full Text] [Related]
17. Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.
Li M; Zhou R; Shan Y; Li L; Wang L; Liu G
Oncotarget; 2016 Sep; 7(36):58531-58542. PubMed ID: 27542271
[TBL] [Abstract][Full Text] [Related]
18. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
19. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
Liu Y; Zhang QY; Qian N; Zhou RL
Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma.
Kang Y; Yin M; Jiang W; Zhang H; Xia B; Xue Y; Huang Y
Am J Surg; 2012 Nov; 204(5):677-83. PubMed ID: 22578410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
